Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in. ...Middle East

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily make copies of Novo Nordisk’s semaglutide. The gambit boosted the telehealth firm’s stock price, and executives made millions selling shares.

Read More Details
Finally We wish PressBee provided you with enough information of ( Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in. )

Also on site :

• Denmark Reconsiders Nuclear Power Ban After Four Decades
• Cronofy sichert sich 15 Millionen Pfund BGF-Investition, um das Wachstum anzukurbeln
• Scala AI City: Brazil's Ministry of Mines and Energy Approves 5 GW Power Connection for Data-Center City in Rio Grande do Sul